![](https://investorshub.advfn.com/uicon/486527.png?cb=1571677899)
Thursday, July 07, 2016 10:56:34 PM
So with NO ONE of REPUTE to handle the uncertainty amongst institutional holders and more importantly, that of non diversified retail hands with deep pockets which only an institution can provide...... this clearly explains the horrific devastation to NWBO shrs. WHY do you think I've emphasized the need for a Baker Bros since Aug 2014.
HAD CEO Linda Powers done it's $130 mln of underwritings that has been handled by HC Wainwright (big fees but NO after market support!!) and INSTEAD decided to use Charden Capital with Dr. Gbola Amusa MD CFA on board since 2014,..... you would have NOT had this experience PERIOD! Proper placement of those $130 mln of NWBO shares ARE KEY!
Clearly NWBO Bd of Dir. Dr. Navid Malik had to be responsible for introducing NWBO to Woodford as well as in Tuesday's small direct private placement done by Charden Capital due in no small part to Navid's friendship with Dr. Gbola Amusa MD CFA
So without a strong foundation of US investor support mechanism in place, it has been EASY PICKINGS for AFraudstein's VAST Manipulator Network to DISTORT, FABRICATE: witness the aftermath of PhaseV report!! and the dissension it caused for Neil Woodford. It would not have happened to ie, Baker Bros
Great science.... but without the key necessary ingredients in place of both an experienced FDA Regulatory Affairs especially in PH 3 AND the clearly necessary after market support
As a public company, science can only take you so far, especially if one wants to go it alone.With very few exceptions, way too nerve wracking for an investor.
IMHO it did NOT have to happen this way!
My 2 cents.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM